News
IDIBELL and ICFO researchers have developed a technology that predicts metastasis in breast cancer
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) and The Institute of Photonic Sciences (ICFO) have collaborated on the development of a diagnostic tool that identifies the metastatic ability of breast cancer cells. The analysis is based on the characterization of the lipid component of the cells, which is indicative of malignancy. This has allowed […]
Eva Pros, UB PhD Extraordinary Award
The thesis of Eva Pros, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO), has been awarded with the Extraordinary Doctorate from the University of Barcelona among the theses defended in the Faculty of Biology during the 2010-2011 course. The thesis, entitled “Neurofibromatosi de tipus 1: Anàlisi de mutacions que […]
An epigenetic difference in twins could explain the different risk of breast cancer
Monozygotic twins have the same genome, that is, the same DNA molecule in both siblings. Despite being genetically identical, both twins may have different diseases at different times. This phenomenon is called “twin discordance”. But how can people who have the same genetic sequence present different pathologies and at different ages? The explanation partly lies […]
Matias Hidalgo: ”The ciliated cells of inner ear can be regenerated in birds”
The past IDIBELL Seminar from October 5th, entitled “Differentiation of sensory elements of vertebrates inner ear: growth factors and regeneration”, was given by Dr. Matías Hidalgo Sánchez, Doctor of Biology at the University of Extremadura. The conference was held in the Auditorium of the University of Barcelona (Campus Bellvitge). The inner ear consists of a […]
IDIBELL and ICO researchers, awarded by the Children’s Tumor Foundation
The selected project is entitled “Targeting NF‐1 associated MPNST with aurora kinase inhibitors” and is awarded with the maximum compensation in their category, with $50,000. It is intended for the use of aurora kinase inhibitors to treat animal models generated in the ICO and IDIBELL premises.
The epidermal stem cells contribute to the development of squamous cell carcinoma
Researchers from the IDIBELL have led a study demonstrating that the expression of human papillomavirus oncoproteins in hair follicle (epidermal region where hair is regenerated) stem cells induces the development of skin carcinomas. These studies show that the origin of certain skin carcinomas resides in the altered function of stem cells. The skin squamous cell […]
La Vanguardia publishes an opinion article on research, by the IDIBELL general manager
The newspaper La Vanguardia publishes on Sunday, October 7th, an opinion article written by the IDIBELL general manager, Emilià Pola, on the future of the research and development in the world and in Catalonia. Pola highlights that “every biomedical researcher makes possible a business of 400,000 euros per year, five times more than it costs”. […]
Annual Report 2011
In 2011, IDIBELL have continued increasing its scientific output focused on improving the health of people. Our researchers have continued publishing in top international journals and participating in leading research projects. The annual report 2011 highlights the most important facts of the year at the centre. A new feature of this edition is the inclusion […]
IDIBELL leads a European project on developing strategies against liver disease
IT-LIVER is a 3.3-million Euros project funded by European Commission under its FP7 Marie Curie Actions. This project will be carried out by 8 academic-research institutions and 4 industrial partners from six European countries. The coordinator of IT-LIVER is Isabel Fabregat, head of the Biological clues of the invasive and metastatic phenotype group of the […]